PivotKara Swisher Calls It Now: the Paramount Merger Won’t Go Through | Pivot
CHAPTERS
- 0:00 – 3:26
Paramount–WBD deal freeze: the TRO, ticking fees, and why “delay” is the real weapon
Kara and Scott unpack the court-ordered pause of the Paramount Skydance–Warner Bros. Discovery merger and why the market reads it as bad news. They explain how a temporary restraining order and a massive ticking fee can drain value even if the companies ultimately win in court.
- •Pause follows a federal TRO; Paramount frames it as a “win,” but shares hit a 52‑week low
- •Ticking fee: $650M per quarter starting in October; breakup fee risk if deal collapses
- •Scott argues the legal case is weak but delay can extract concessions and create political leverage
- •Investors price in meaningful odds the deal won’t close
- 3:26 – 4:31
Merger arb signals: what the spread says about deal probability and downside
They translate the gap between the deal price and trading price into a market-implied chance of failure. The discussion emphasizes how, for shareholders, “winning” legally can still be losing economically if uncertainty persists.
- •Kara cites the big delta between announced price and current trading price as a red flag
- •Scott explains merger arbitrage mechanics and how spreads reflect perceived risk
- •If the deal fails, Kara expects the stock to collapse
- •Core claim: the market is voting that closing is far from certain
- 4:31 – 6:43
Kara’s legal read: Paramount ‘blinked,’ avoided a bad ruling, and signaled weakness
Kara argues Paramount chose a damaging business pause to avoid losing on a preliminary injunction, which would have been devastating and hard to overturn. They walk through why the litigation timeline itself may kill the deal.
- •Theory: Paramount feared losing on the PI and preferred “no ruling” over a bad ruling
- •Delay strategy: you don’t have to win, you just have to stall
- •Scheduling fight ahead; judge appears in no rush, appeal path extends the timeline
- •Economic drag: coordination savings erode; reputational and strategic paralysis mounts
- 6:43 – 9:34
Endgames: settlement, divestitures, or economic collapse before verdict
They map the most plausible outcomes—from states winning and blocking the merger, to structural remedies, to a deal dying purely from cost and time. Even a Paramount win could trigger prolonged appeals and steep ticking fees.
- •Scenario planning: permanent injunction vs settlement with structural remedies (divestitures)
- •Deal may collapse economically if ticking fees exceed remaining value
- •Even a win could mean $1B+ in fees plus reputational damage and likely appeal
- •Kara’s bottom line: time is not on Paramount’s side
- 9:34 – 16:32
The Oracle/OpenAI ‘fulcrum’: Ellison staying power and political blowback risk
Scott posits the deal’s fate may hinge less on antitrust merits and more on Oracle’s stock and OpenAI momentum, because that’s the financial backstop. Kara adds that midterm politics and prior newsroom meddling could intensify opposition and scrutiny.
- •Scott: combined share of viewing may not look monopolistic versus YouTube/Netflix, so legal closure is plausible
- •Real risk is affordability: Oracle as a “tracking stock” for OpenAI; if Oracle falls, financing patience shrinks
- •Kara: company overconfidence after prior regulatory wins; targeted lawsuit only needs to delay
- •Midterms and the CBS/CNN rhetoric could create a Democratic “buzzsaw” of political pressure
- 16:32 – 24:13
White House Correspondents’ Dinner aftermath: why the event feels broken
They argue the rescheduled WHCD amplified institutional decline and produced a globally embarrassing spectacle. Both contend journalists were put in a no-win situation and that the dinner should be reinvented—or ended.
- •Trump’s appearance turns into attacks and uncomfortable moments in the room
- •Kara: the dinner makes people hate journalists; best choice would’ve been not attending
- •Scott: it’s like legacy media awarding itself relevance; “bury it” or don’t invite the president
- •Theme: institutions ceding power and losing legitimacy in public view
- 24:13 – 28:02
Meta’s ‘AI optimism’ ad: authenticity gap, surveillance vibes, and the need to stop talking
Scott and Kara roast Meta’s branding push, arguing it invites scrutiny because the company’s incentives don’t match the message. They contrast glossy ads with real product harms and propose what reputational repair could look like.
- •Ad positions Meta as pro-connection and pro-people; hosts call it cynical and tone-deaf
- •Critiques include teen mental health impacts, “stalker glasses,” and surveillance capitalism
- •Better path: substantive actions (vocational training, safety moves) and quieter PR vs big sentiment ads
- •Advice: perform, fix, and ‘keep it to yourself’—don’t plead to be liked
- 28:02 – 40:49
Tech’s ‘hey girl’ outreach and EU regulation: live by Europe’s rules, don’t tariff tantrum
The conversation widens to how tech leaders are suddenly courting critics amid a political vibe shift. On Trump’s EU trade probe after a Google fine, Kara argues the U.S. failure to regulate leaves Europe as de facto regulator—and tariffs are a blunt, inflationary response.
- •Kara: many tech firms are re-engaging critics to preempt “payback” politics
- •Trump threatens tariffs over EU antitrust enforcement; Kara calls tariffs economically harmful and ineffective
- •EU has become America’s tech regulator because the U.S. won’t act
- •If U.S. companies operate in Europe, they must comply with European laws
- 40:49 – 48:08
Peptides and the gray market: real promise vs hype, weak evidence, and safety risks
They tackle the wellness boom around peptides, distinguishing validated drugs like GLP‑1s from influencer-fueled stacks with limited data. Kara stresses sourcing and oversight dangers, while Scott argues the trend reflects declining trust in health institutions.
- •GLP‑1s (peptides) are evidence-backed, but many popular ‘longevity’ peptides aren’t well proven
- •Kara: gray-market sourcing (often overseas) and compounding variability can be dangerous
- •Scott: people DIY medicine due to institutional distrust; insists on medical supervision and labs
- •Shared caution: buyer beware; don’t treat peptides as cure-alls without strong studies
- 48:08 – 50:09
Wins and fails: Buttigieg family incident, WHCD as a ‘loss,’ and Ukraine’s asymmetric pressure
Kara’s fail spotlights a policing breakdown where dubious allegations led to Pete Buttigieg being separated from his children without proper vetting. Scott reiterates WHCD as a reputational loss, then highlights Ukraine’s innovative strategy—targeting consumer infrastructure to create visible pain inside Russia.
- •Fail: authorities separated Buttigieg from his four-year-old twins based on unvetted, biased allegations
- •Kara suggests legal action; emphasizes harm to children and institutional negligence
- •Scott’s loss: WHCD should be canceled/reinvented after repeated public dysfunction
- •Win: Ukraine strikes Wildberries (Russia’s Amazon) to generate elite/public outrage and disrupt supply chains
- 50:09 – 58:11
Culture corner and wrap: Broadway ‘Cats: Jellicle Ball,’ ‘Ride or Die,’ and listener call-ins
Kara recommends audience-forward cultural experiences as a counterweight to political and tech cynicism, praising the ‘Cats’ Jellicle Ball production and the Amazon show ‘Ride or Die.’ They close with listener prompts and a plug for Kara’s other interview content.
- •Kara win: ‘Cats’ Jellicle Ball as joyful, communal, human-centered art
- •Additional rec: ‘Ride or Die’ with Octavia Spencer and Hannah Waddingham
- •Invitation for listeners to submit questions and (jokingly) Meta taglines
- •Show plugs and sign-off for upcoming episodes
